-
121
Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
Published 2021-01-01“…We herein described two cases of metastatic renal collecting duct carcinoma treated with a combination immunotherapy consisting of nivolumab and ipilimumab. …”
Get full text
Article -
122
Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy
Published 2018-01-01“…Following a negative workup for an underlying etiology, immunotherapy-induced RTA was suspected. Withholding of the offending agent and initiation of steroid therapy resulted in adequate response. …”
Get full text
Article -
123
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
Published 2025-02-01“…However, a significant proportion of patients exhibit primary or acquired resistance, limiting the overall efficacy of immunotherapy. This review provides a comprehensive analysis of the mechanisms underlying immunotherapy resistance in GC, including the role of the tumor immune microenvironment, dynamic PD-L1 expression, compensatory activation of other immune checkpoints, and tumor genomic instability. …”
Get full text
Article -
124
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
125
Immunotherapy Responsive Autoimmune Subacute Encephalitis: A Report of Two Cases
Published 2010-01-01Get full text
Article -
126
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
127
Editorial: Advances in immunotherapy of hepatic-biliary-pancreatic cancers, volume II
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
128
Immunotherapy in ovarian cancer: spatial functional genomics to unravel resistance mechanisms
Published 2025-01-01Get full text
Article -
129
Immunoregulatory Effects of Subcutaneous Immunotherapy on Lymphocyte Subgroups and Cytokines in Children with Asthma
Published 2019-01-01“…The immunologic effects of subcutaneous immunotherapy (SCIT) exerts on allergic asthma remain still largely unknown. …”
Get full text
Article -
130
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
Published 2022-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
131
Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma
Published 2025-01-01Get full text
Article -
132
The Relationship Between the Modulation of Intestinal Microbiota and the Response to Immunotherapy in Patients with Cancer
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
133
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
Published 2022-09-01Subjects: “…immunotherapy…”
Get full text
Article -
134
Innovative applications and future trends of multiparametric PET in the assessment of immunotherapy efficacy
Published 2025-01-01Subjects: Get full text
Article -
135
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
136
Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
Published 2012-01-01“…The therapeutic options remain limited for advanced MM, and those directed to the neoplastic cells have not brought major survival advantage so far. Immunotherapy is another targeted option. Ipilimumab, a monoclonal antibody directed to CTLA-4 present on cytotoxic T cells boosts immunity, particularly its anti-MM activity. …”
Get full text
Article -
137
Response of Immunotherapy to Tumour-TICLs Interactions: A Travelling Wave Analysis
Published 2014-01-01“…We present a travelling wave analysis of a tumour-immune interaction model with immunotherapy. We use the geometric treatment of an apt-phase space to establish the intersection between stable and unstable manifolds. …”
Get full text
Article -
138
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
Published 2024-09-01Subjects: Get full text
Article -
139
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
Published 2015-01-01“…In this review, we describe a process, which integrates next generation sequencing based cancer mutanome mapping, in silico target selection and prioritization approaches, and mRNA vaccine manufacturing and delivery into a process we refer to as MERIT (mutanome engineered RNA immunotherapy).…”
Get full text
Article -
140
Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
Published 2025-02-01Subjects: Get full text
Article